Zevra Therapeutics, Inc. (ZVRA) PT Raised to $29 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Kristen Kluska raised the price target on Zevra Therapeutics, Inc. (NASDAQ: ZVRA) to $29.00 (from $25.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
